Fig. 9

Drug sensitivity analysis. (A) Sensitivity analyses of axitinib, erlotinib, sorafenib, and sunitinib in the high- and low-risk patient groups. (B) Differences in target gene expression between the low- and high-risk groups. *p < 0.05, **p < 0.01, ***p < 0.001. Abbreviations: IC50, half-maximal inhibitor concentration